RYAM RAYONIER ADVANCED MATERIALS INC. Insider Trading

RYAM CEO Bloomquist buys 53,533 shares at $4.71; stock up 22.0% in 30 days despite -$363.2M net loss and unprofitable year.

CEO DeLyle W Bloomquist purchased 53,533 shares (53.5K shares) at $4.71 on 2025-08-12, expanding his position by 11.0% to 539,557 shares (539.6K shares) total. The transaction occurred when RAYONIER ADVANCED MATERIALS' stock was trading -49.5% from its 52-week high of $10.00, and the company reported a net income of -$363.2M over its most recent full fiscal year. However, the stock has recovered sharply: up 22.0% in the 30 days since his purchase and up 20.5% over 90 days. Notably, his sole prior buy at RYAM (on 2025-05-16) also achieved a 90-day positive return of +27.9%, indicating a consistent pattern of buying before subsequent gains at this specific ticker. The fundamental picture remains concerning—the company is unprofitable and faces flat revenue growth—yet the insider's purchase timing has aligned with material price rebounds both this year and previously.

RYAM CEO buys 63,291 shares at $3.95 amid -40.6% 90-day decline and ongoing losses

Bloomquist DeLyle W, President and CEO of Rayonier Advanced Materials, purchased 63,291 shares at $3.95 on 2025-05-16, increasing his holdings from 422,733 to 486,024 shares. The company has reported a negative net income of $-31,970,000.00 over its most recent full fiscal year and faces structural headwinds: revenue growth of -0.8% annually, with the stock down 40.6% over the past 90 days and trading at $4.24, down 57.6% from its 52-week high of $10.00. A CEO equity purchase during a period of significant stock weakness and ongoing operational losses warrants investor attention to understand whether this reflects conviction in a turnaround or represents a routine rebalancing or compensation-related activity.

Director Eric Bowen purchases 12,500 shares of RYAM at $8.04; stock now at $7.95, down 13.7% in 30 days, amid negative earnings.

Eric Bowen, a director of Rayonier Advanced Materials, purchased 12,500 shares at $8.04 on 2024-12-13, establishing an initial position in the company. The purchase occurs as RYAM trades near recent lows, down 13.7% over the past 30 days and 20.5% below its 52-week high of $10.00. The company's fundamentals present headwinds: net income was negative at $-32.6M over the most recent full year, and revenue contracted 4.3% year-over-year, with the latest quarter showing ongoing losses. While an insider purchase can reflect board-level confidence in value, this transaction's modest size (12,500 shares representing a small fraction of the $524.0M market cap) and the company's current unprofitability warrant careful monitoring of whether this signals genuine conviction or merely opportunistic entry at depressed levels.